Principal Financial Group
DTIL icon

Principal Financial Group’s Precision BioSciences DTIL Stock Holding History

Principal Financial Group’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-22,705
Closed -$2.1M – 2543
2022
Q1 		$2.1M Sell
22,705
-13
-0.1% -$1.77K ﹤0.01% 1856
2021
Q4 		$5.04M Buy
22,718
+6,408
+39% +$1.79M ﹤0.01% 1662
2021
Q3 		$5.65M Buy
16,310
+943
+6% +$320K ﹤0.01% 1639
2021
Q2 		$5.77M Buy
15,367
+1,404
+10% +$422K ﹤0.01% 1671
2021
Q1 		$4.34M Buy
13,963
+1,063
+8% +$372K ﹤0.01% 1704
2020
Q4 		$3.23M Buy
12,900
+563
+5% +$138K ﹤0.01% 1691
2020
Q3 		$2.28M Buy
12,337
+367
+3% +$73K ﹤0.01% 1711
2020
Q2 		$2.99M Buy
11,970
+4,303
+56% +$942K ﹤0.01% 1604
2020
Q1 		$1.39M Hold
7,667
– – ﹤0.01% 1682
2019
Q4 		$3.19M Buy
7,667
+2,017
+36% +$634K ﹤0.01% 1643
2019
Q3 		$1.42M Buy
5,650
+1,505
+36% +$490K ﹤0.01% 1776
2019
Q2 		$1.65M Buy
4,145
+1,645
+66% +$662K ﹤0.01% 1752
2019
Q1 		$1.35M Buy
+2,500
New +$1.33M ﹤0.01% 1791

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Principal Financial Group's DTIL Position: Q2 2022 in Review

Principal Financial Group sold out of Precision BioSciences (DTIL) in Q2 2022, closing a stake of 22,705 shares — an estimated $2.1M sold.

Principal Financial Group first reported a position in DTIL in Q1 2019 and held it in 13 quarters. The position peaked at $5.77M in Q2 2021. 119 funds tracked by Wall St. Rank hold DTIL as of Q2 2022.

  • Principal Financial Group reported no remaining Precision BioSciences position as of Q2 2022 after selling out during the quarter.
  • Principal Financial Group sold 22,705 Precision BioSciences shares in Q2 2022, an estimated $2.1M.
  • Principal Financial Group first reported a position in Precision BioSciences in Q1 2019 and held it in 13 quarters.
  • Principal Financial Group's Precision BioSciences position peaked at $5.77M in Q2 2021.
  • 119 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2022.

Based on Principal Financial Group's 13F filing for Q2 2022, filed 10 Aug 2022.